LEGN Legend Biotech Corporation ADRs

Legend Biotech is a clinical stage biopharmaceutical company engaged in the discovery and development of novel cell therapies in hematology/oncology, infectious diseases and auto-immune disorders. Legend operates in the USA, mainland China and Ireland. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$46.80  -0.19 (-0.40%)
As of 09/28/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  
IPO date:  01/02/2015
Outstanding shares:  144,714,048
Average volume:  344,557
Market cap:   $6,591,724,886
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    52490G102
ISIN:        US52490G1022
Sedol:      BMX9K07
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy